Author: Peter Mansell

Russian clinical trial approvals up 9% in 2008

The Russian agency cleared a total of 615 new trials in 2008, 282 of which were Phase III studies, 152 Phase II, 62 Phase IV and 38 Phase I, according to the latest report from Moscow-based contract research organisation (CRO) Synergy Research Group. The number of Phase III trials rose by 22% over 2007, while there were 4% fewer Phase II studies and 3% more Phase IV studies. The Phase I tally rose by 19% year-on-year.

Read More

Covance opens new offices in Ukraine, Slovakia, Israel

Recession effects and the strong dollar aside, Covance is pushing ahead with beefing up its presence in new markets for clinical research. The US-based contract research organisation (CRO) has opened clinical development offices in Kiev (Ukraine), Bratislava (Slovakia) and Tel Aviv (Israel) respectively.

Read More

PharmaNet opts for private equity solution

US-based contract research organisation (CRO) PharmaNet Development Group has found a way out of its current financial bind by agreeing to a merger with affiliates of private equity firm JLL Partners.

Read More

Perceptive-AG Mednet alliance seeks imaging efficiencies

Perceptive Informatics, the eClinical subsidiary of US-based contract research organisation (CRO) Parexel, has formed an alliance with global diagnostic imaging network AG Mednet that aims to improve both the efficiency with which medical images are delivered in clinical trials and the quality of imaging data.

Read More